A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
The ADOPT-PGx study examined the impact of genotype-guided opioid prescribing on postoperative pain management. Results from the study were recently published in JAMA Network Open, accompanied by an invited commentary reflecting on the findings and their implications for pharmacogenetics in ...
CPIC-PGRN Meeting: Diversifying PGx Science To Improve Implementation
May 10, 2022 - May 12, 2022
Network affiliate, OneOme, will present “The importance of genotyping multiethnic high-frequency CYP2C9 alleles in pharmacogenomic testing.” The CPIC: PGRN In-person Meeting will be held May 10, 11, and 12 at the University of Colorado Anschutz.